GenoSplice publications (before 2010)

Authorship on relevant publications about our technology:

• Nonsense-mediated mRNA decay impacts MSI-driven carcinogenesis and anti-tumor immunity in colorectal cancers.
El-Bchiri J, Guilloux A, Dartigues P, Loire E, Mercier D, Buhard O, Sobhani I, de la Grange P, Auboeuf D, Praz F, Fléjou JF, Duval A. PLoS ONE. 2008, 3(7):e2583.
• Regulation of H-ras splice variant expression by cross talk between the p53 and nonsense-mediated mRNA decay pathways.
Barbier J, Dutertre M, Bittencourt D, Sanchez G, Gratadou L, de la Grange P, Auboeuf D. Mol Cell Biol. 2007, 27(20):7315-33.
• A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants.
de la Grange P, Dutertre M, Correa M, Auboeuf D. BMC Bioinformatics 2007, 8:180
• ASEtrap: a biological method for speeding up the exploration of spliceomes.
Thill G, Castelli V, Pallud S, Salanoubat M, Wincker P, de la Grange P, Auboeuf, D, Schächter V, Weissenbach J. Genome Res. 2006, 16(6):776-86.
• FAST DB: a website resource for the study of the expression regulation of human gene products.
de la Grange P, Dutertre M, Martin N, Auboeuf D. Nucleic Acids Research 2005, 33(13):4276-4284.

Publications using/citing our technology:

• Widespread Estrogen-Dependent Repression of microRNAs Involved in Breast Tumor Cell Growth.
Maillot G, Lacroix-Triki M, Pierredon S, et al. Cancer Research 2009, 69(21):OF1-9.
• PRPF31 Alternative Splicing and Expression in Human Retina.
Tanackovic G, Rivolta C. Ophthalmic Genetics 2009, 30(2):76-83.
• Accurate prediction of NAGNAG alternative splicing.
Sinha R, Nikolajewa S, Szafranski K, Hiller M, Jahn N, Huse K, Platzer M, Backofen R. Nucleic Acids Research 2009, 37(11):3569-3579.
• Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis.
Pendino F, Nguyen E, Jonassen I, et al. Blood 2009, 113(14):3172-3181.
• ASTD: The Alternative Splicing and Transcript Diversity database.
Koscielny G, Le Texier V, Gopalakrishnan C, et al. Genomics 2009, 93(3):213-220.
• The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments.
Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. Clinical Chemistry 2009, 55:611-622.
• Identification of Nuclear and Cytoplasmic mRNA Targets for the Shuttling Protein SF2/ASF.
Sanford JR, Coutinho P, Hackett JA, Wang X, Ranahan W, Caceres JF. PLoS ONE 2008, 3(10): e3369.
• Splice-mediated Variants of Proteins (SpliVaP) – data and characterization of changes in signatures among protein isoforms due to alternative splicing.
Floris M, Orsini M, Thanaraj TA. BMC Genomics 2008, Oct 2;9:453
• WD-40 repeat protein SG2NA has multiple splice variants with tissue restricted and growth responsive properties.
Sanghamitra M, Talukder I, Singarapu N, Sindhu KV, Kateriya S, Goswami SK. GENE 2008, 420(1):48-56.
• SpliceCenter: A suite of web-based bioinformatic applications for evaluating the impact of alternative splicing on RT-PCR, RNAi, microarray, and peptide-based studies.
Ryan MC, Zeeberg BR, Caplen NJ, Cleland JA, Kahn AB, Liu H, Weinstein JN. BMC Bioinformatics 2008, 9:313.
• Molecular medicine, gene-expression profiling and molecular diagnostics: putting the cart before the horse.
Bustin SA. BIOMARKERS IN MEDICINE 2008, 2(3): 201-207.
• The evolution of alternative splicing in the Pax family: The view from the basal chordate amphioxus.
Short S, Holland LZ. JOURNAL OF MOLECULAR EVOLUTION 2008, 66(6): 605-620.
• Characterization of HSD17B1 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer.
Plourde M, Samson C, Durocher F, Sinilnokova O, Simard J. J Steroid Biochem Mol Biol. 2008, 109(1-2): 115-128.
• ProSAS: a database for analyzing alternative splicing in the context of protein structures.
Author(s): Birzele F, Kuffner R, Meier F, Oefinger F, Potthast C, Zimmer R. Nucleic Acids Research 2008, 36(Sp. Iss.): D63-D68.
• Alternative splicing of U12-type introns.
Chang WC, Chen HH, Tarn WY. FRONTIERS IN BIOSCIENCE 2008, 13: 1681-1690.
• Large-scale pathways-based association study in amyotrophic lateral sclerosis.
Kasperaviciute D, Weale ME, Shianna KV, Banks GT, Simpson CL, Hansen VK, Turner MR, Shaw CE, Al-Chalabi A, Pall HS, Goodall EF, Morrison KE, Orrell RW, Beck M, Jablonka S, Sendtner M, Brockington A, Ince PG, Hartley J, Nixon H, Shaw PJ, Schiavo G, Wood NW, Goldstein DB, Fisher EM. Brain 2007, 130: 2292-2301.
• Comparative genomics and evolution of alternative splicing: The pessimists’ science.
Artamonova II, Gelfand MS. CHEMICAL REVIEWS 2007, 107(8): 3407-3430.
• Identification of human olfactory cleft mucus proteins using proteomic analysis.
Author(s): Debat H, Eloit C, Blon F, Sarazin B, Henry C, Huet JC, Trotier D, Pernollet JC. J Proteome Res. 2007, 6(5): 1985-1996.
• Coregulators: transducing signal from transcription to alternative splicing.
Author(s): Auboeuf D, Batsche E, Dutertre M, Muchardt C, O’Malley BW. Trends Endocrinol Metab. 2007, 18(3): 122-129.
• SpliceMiner: a high-throughput database implementation of the NCBI Evidence Viewer for microarray splice variant analysis.
Kahn AB, Ryan MC, Liu HF, Zeeberg BR, Jamison DC, Weinstein JN. BMC Bioinformatics 2007, 8:75.
• Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice.
Kress C, Gautier-Courteille C, Osborne HB, Babinet C, Paillard L. Mol Cell Biol. 2007, 27(3): 1146-1157.
• TassDB: a database of alternative tandem splice sites.
Hiller M, Nikolajewa S, Huse K, Szafranski K, Rosenstiel P, Schuster S, Backofen R, Platzer M. Nucleic Acids Res. 2007, 35(Sp. Iss.): D188-D192.
• Mechanisms directing the nuclear localization of the CtBP family proteins.
Verger A, Quinlan KGR, Crofts LA, Spanò S, Corda D, Kable EP, Braet F, Crossley M. Mol Cell Biol. 2006, 26(13): 4882-4894.
• Our favourite alternative splice site.
Lerivray H, Mereau A, Osborne HB. Biol Cell. 2006, 98(5): 317-321.

Comments are closed.